The Aperlena Verdict
Open raceNo supplier dominates: 256 different companies have won the last 663 comparable contracts from this buyer over 5 years. This is a genuinely open race.
- Expected final price vs the published estimate
- 0%
Based on 663 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.
Summary
Machine-generated summaryThis public tender covers the purchase of a fixed-dose combination antiretroviral medicine containing efavirenz 600 mg, emtricitabine 200 mg and tenofovir disoproxil 245 mg, supplied as tablets for oral use. The medicine is used in the treatment of HIV infection. The procurement concerns the supply of pharmaceutical products, delivered in accordance with the quantities and conditions set out in the tender documents. The contract reference is CP no. 181A000010, and the documents were published in Portuguese.
Official source
Source: BASE - Portal dos Contratos Públicos (IMPIC)
Always verify details on the official notice.
Report an error in this notice
Last verified against BASE - Portal dos Contratos Públicos (IMPIC) 5 days ago
More from this buyer
Full buyer profile124 open tenders right now
- 269A000063 - Aquisição de Produtos de Apoio, para o Serviço de Medicina Física e Reabilitação (MFR), para atribuição de Ajudas Técnicas a utentes no ano de 2026 2 days left
- Aquisição de solução de segurança de perímetro 3 days left
- Software development services for databases - Acquisition of application support and maintenance services for an SAP solution for 2026, 2027, 2028 and 2029 17 days left
Who usually wins this buyer's contracts in this sector
| Company | Wins | Total awarded | Last win |
|---|---|---|---|
| GENERIS FARMACÊUTICA S.A | 17 | €146,661 | Sep 2026 |
| ACCORD HEALTHCARE UNIPESSOAL LDA | 16 | €363,988 | Aug 2026 |
| FRESENIUS KABI PHARMA PORTUGAL, LDA. | 16 | €313,366 | Sep 2026 |
| GENERIS - FARMACEUTICA, S.A. | 15 | €357,803 | Sep 2026 |
| XPHARMA, Lda. | 14 | €51,218 | Sep 2026 |
Based on 663 awards with a linked company profile over the last 5 years.
What this buyer has paid before
Based on 668 comparable contracts this buyer awarded in this sector over the last 4 years.
- Lower quartile
- €1,448
- Median award
- €7,005
- Upper quartile
- €28,819
This tender is estimated 2523.3% above that median
Most recent awards
- 261Y000617/13559 - IMIPENEM 500 MG + CILASTATINA 5 €102,563
- 261G001039/13559 - AC MONOCLONAL ANTI CD123-APC €810
- 261Y000618/13559 - BRIGAtinib 30 MG COMP €2,212
- 261G001021/13559 - VÁRIOS REAGENTES €810
- 261X000268 - CANABIDIOL 100MG/ML SOL ORAL FRS 100ML €17,765
Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.
Similar tenders
1
day left
€87,610
est. value
1
day left
€17,700,000
est. value
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €11,376,946
- Buyer track record on Aperlena
- 2,798 notices tracked · 995 awarded
- €42,909,010 in awarded contracts
Never miss a tender like this
1,132 new notices in Medical equipment & pharmaceuticals in Portugal in the last 7 days. Get an email when new ones appear. Free.
Set up my alert